DIRS.INFO top alerts submit data jurnalism about API
login
Top related persons:
Morgan Stanley - 2 — CNBC's Michael Bloom - 2 JPM - 1 JPMorgan - 1 KeyBanc - 1 Wells - 1 D.A - 1 Davidson - 1
Top related locs:
U.S China Texas GLP DaVita ResMed
Top related orgs:
JPMorgan - 2 Motors - 1 Ford - 1 GM - 1 Nvidia - 1 MU - 1 BMO - 1 prem - 1

Search resuls for: "AtriCure"


4 mentions found


☆ Here are Tuesday's biggest analyst calls: Nvidia, Tesla, Apple, Roblox, Tesla, Qualcomm, Disney & more
  + stars: | 2024-04-23 | by ( Michael Bloom | ) www.cnbc.com   time to read: +7 min
Here are Tuesday's biggest calls on Wall Street: Loop initiates MongoDB as buy Loop sees growth accelerating for the developer data platform company. JPM reiterates General Motors and Ford as overweight JPMorgan said the stocks will benefit from "lower commodities & higher production outside China." JPMorgan upgrades Assai to overweight from neutral JPMorgan said it sees improving trends and better visibility for the Brazilian wholesaler. JPMorgan upgrades Roblox to overweight from neutral JPMorgan said it sees a "compelling entry point" for the stock. JPMorgan downgrades Five Below to neutral from overweight JPMorgan downgraded Five Below due to "ongoing macro pressure."
Persons: JPM, JPMorgan, KeyBanc, Wells, D.A, Davidson, Davidson's, Berenberg, Morgan Stanley, Harley, Evercore, it's bullish, it's, Tesla, Rosenblatt, Oppenheimer, Dwight, Key, Truist, Wolfe, Warner, Price Organizations: Motors, Ford, GM, Nvidia, MU, BMO, prem, NICE, JPMorgan, Barclays, Apple, Albertsons, Catalyst Watch, NOVA, Penn Entertainment, PENN, ESPN Bet, Benchmark, Qualcomm, Warner Brothers, Warner, HBO Locations: China, Texas, U.S
☆ This maker of an atrial fibrillation device has nearly 70% upside, JMP Securities says
  + stars: | 2023-10-23 | by ( Pia Singh | ) www.cnbc.com   time to read: +2 min
Investors should scoop up shares of medical device provider AtriCure , according to JMP Securities, which expects the company to be a winner in one burgeoning medical device market. AtriCure develops, manufactures and sells devices that are used for the treatment of atrial fibrillation, or Afib; left atrial appendage management, or LAAM; and post-operative pain. The company's stock price has declined just about 19% so far this year, with almost all of that occurring this quarter. ATRC YTD mountain AtriCure stock. AtriCure's pain management division "adds an attractive layer of growth that should outpace ATRC's legacy product portfolios," Stauder said.
Persons: Daniel Stauder, Stauder, bode, AtriCure, — CNBC's Michael Bloom Organizations: JMP Securities
☆ Which stocks might be disrupted next by Ozempic and other GLP-1 drugs
  + stars: | 2023-10-12 | by ( Christina Cheddar Berk Samantha Subin | Christina Cheddar Berk | Samantha Subin | ) www.cnbc.com   time to read: +11 min
How GLP-1 drugs work Sorting through the facts reveals some likely winners and losers. LLY YTD mountain Eli Lilly shares year to date performance It is still early days for GLP-1 medications. Many have seen the rise of GLP-1 drugs as a threat to the medical device industry. Also, not all patients are able to tolerate GLP-1 drugs, which can cause side effects such as nausea. Among other medtech stocks, Plovanic sees GLP-1 drugs as an "incremental positive" for Dexcom, which makes continuous glucose monitors (CGMs), but an "incremental negative" for insulin pump makers like Insulet.
Persons: Insulet, Medtronic, Dexcom, BAX, NASH, Eli Lilly, Peter Verdult, Lilly, Eli Lilly aren't, Piper Sandler, Wegovy, Yasmeen Rahimi, Robbie Marcus, Marcus, hasn't, Baxter, David Low doesn't, William Plovanic, Craig Wong, Pan, Plovanic, Matt O'Brien, O'Brien, Rippling, Simeon Gutman, Morgan Stanley, Gutman, — CNBC's Michael Bloom Organizations: Novo Nordisk, Baxter International, Baxter, GLP, Citi, Novo, Bank of America, Viking Therapeutics, Pharmaceuticals, Pfizer, Amgen, Companies, Fisher, Reuters, Inspire, Systems, JPMorgan, RBC Capital, Walmart, underperformance Locations: GLP, U.S, DaVita, ResMed
☆ Here are JPMorgan's top stock picks heading into February
  + stars: | 2023-02-01 | by ( Hakyung Kim | ) www.cnbc.com   time to read: +2 min
JPMorgan added fresh names to its top stock picks for February, including a medical tech company that's rallied sharply to begin the year. For February, JPMorgan added five new names to its Focus List: Cenovus Energy , CMS Energy , Rogers Communications , Stryker and Treace Medical Concepts . The medical tech stock is up 12% year to date. JPMorgan said new additions CMS Energy and Cenovus Energy are uniquely positioned within the industry, according to the note. Amazon's stock fell more than 30% during the past 12 months, but it has rallied to start the year, up more than 24% in 2023.
0 next >>
Total: 4